跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21 条关于
“IO102/IO103”
全部
21
临床试验
10
药物
1
机构
0
资讯
10
去年
IO102-IO103 Vaccine Plus Pembrolizumab Shows Promise in NSCLC
2年前
IO102-IO103 Cancer Vaccine Plus Pembrolizumab Shows Promise in Head and Neck Cancer
去年
IO Biotech Completes Enrollment in Phase 2 Trial of IO102-IO103 Cancer Vaccine
2年前
IO Biotech's Melanoma Trial of IO102-IO103 Combination Therapy to Continue
2年前
IO Biotech's IO102-IO103 Plus Pembrolizumab Shows Promise in Head and Neck Cancer
9个月前
IO Biotech's Cancer Vaccine Shows 25.5-Month Median Progression-Free Survival in Five-Year Melanoma Study
去年
IO Biotech's Novel Immune-Modulatory Cancer Vaccine Shows Promise in Phase 3 Trials
去年
IO Biotech Faces Nasdaq Delisting Risk Despite Promising Cancer Vaccine Advances
去年
IO Biotech's Cylembio Cancer Vaccine Misses Primary Endpoint in Phase 3 Melanoma Trial
去年
Melanoma Treatment Landscape Evolves with Novel Immunotherapies and Targeted Approaches